T1	Participants 875 941	patients with coronary heart disease (CHD) or CHD risk equivalents
T2	Participants 977 1146	Eligible patients at National Cholesterol Education Program-Adult Treatment Panel III LDL-C treatment goal on a statin, with or without other lipid-modifying medications
T3	Participants 1725 1846	A total of 2,757 patients were screened at 153 centers in 20 countries, and 1,623 patients were randomized into the trial
T4	Participants 1887 1942	safety outcomes from this trial are anticipated in 2010
